Published in Telemedicine Law Weekly, August 27th, 2005
Study 1: Age and race/ethnicity are predictors of whether women will receive appropriate follow-up of abnormal cervical cancer screening results, report U.S. Centers for Disease Control and Prevention (CDC) researchers.
V.B. Benard and colleagues conducted a study "to determine whether women in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) who had findings on a Papanicolaou (Pap) test of atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesions (LSIL) were followed up in accordance with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.